Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
07/2010
07/14/2010EP2205563A2 Novel histone deacetylase inhibitors
07/14/2010EP2205553A1 Contrast agents
07/14/2010CN101774986A Method for preparing aliskiren and intermediate thereof
07/13/2010US7754898 Method of enantioselective nucleophilic addition reaction of enamide to imine and synthesis method of α-amino-γ-keto acid ester
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/08/2010US20100174090 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia
07/08/2010US20100172967 Compound modified with glycerol derivative
07/07/2010EP2204361A1 13-substituted methacycline compounds
07/07/2010EP2203411A2 N-phenyl anthranilic acid derivatives and uses thereof
07/07/2010EP2203190A1 Contrast agents
07/07/2010EP2203189A1 Contrast agents
07/06/2010CA2393883C Salicylamide derivatives
07/01/2010WO2010072712A1 Biaryl benzylamine derivatives
07/01/2010WO2009047615A3 Novel histone deacetylase inhibitors
07/01/2010US20100168243 Renin Inhibitors
07/01/2010US20100167995 Peptoid compounds
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
06/2010
06/30/2010EP2202220A1 Acetylene compound, salt thereof, condensate thereof, and composition thereof
06/30/2010EP2201945A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP2201944A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP2200971A1 Contrast agents
06/30/2010EP2200656A1 Contrast agents
06/30/2010EP2200655A1 Contrast agents
06/29/2010US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis
06/29/2010US7745662 Polycationic compounds and uses thereof
06/29/2010US7745492 Carboxamido opioid compounds
06/29/2010US7745490 3-hydroxy-N-(3-hydroxy-4-methoxyphenyl)-4-methoxybenzamide, used in the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyloidosis, such as observed non-insulin depepndent diabetes
06/29/2010US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain
06/29/2010US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor
06/24/2010WO2010070093A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation
06/24/2010WO2009101616A9 Novel conjugates for treating neurodegenerative diseases and disorders
06/24/2010US20100160656 7-phenyl-substituted tetracycline compounds
06/24/2010US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use
06/24/2010US20100160265 7-(1,4-dioxenyl) doxycycline; Therapy against tetracycline-resistant organisms; bactericides; bacteriostats; escherichia; straphococcus; enterococcus; anticancer agents; antidiabetic agents
06/24/2010US20100160264 Crystalline solid forms
06/24/2010US20100160263 7,9-substituted tetracycline compounds
06/24/2010US20100159593 Transfection reagents
06/24/2010US20100158996 Ester compound and medical use thereof
06/24/2010CA2746585A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation
06/23/2010EP2197881A1 Process for the manufacture of bridged monobactam intermediates
06/23/2010EP2197835A1 Bicyclic aryl and heteroaryl receptor modulators
06/23/2010EP2197834A2 A novel cationic lipid, a preparation method of the same and a delivery system comprising the same
06/22/2010US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2374346C Inhibitors of memapsin 2 and use thereof
06/17/2010WO2010068649A1 Crystalline forms of a 3-carboxypropyl-aminotetralin compound
06/17/2010US20100152142 Crystalline form ii of tigecycline and processes for preparation thereof
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010CA2745441A1 Crystalline forms of a 3-carboxypropyl-aminotetralin compound
06/16/2010CN101735101A Tartrate of photoactive 2-amino amides
06/10/2010US20100145099 Novel polymorphic forms of milnacipran hydrochloride
06/10/2010US20100144876 Modulator
06/10/2010US20100144869 Conjugates Comprising a gaba-or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
06/10/2010US20100144808 Substituted isoxazoline or enone oxime compound, and pest control agent
06/10/2010US20100144707 Pharmacokinetically improved compounds
06/10/2010US20100144650 Dimeric iap inhibitors
06/10/2010US20100143460 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
06/10/2010US20100143391 Hapten compounds and compositions and uses thereof
06/09/2010EP2194039A1 Process for preparing optically enriched compounds
06/09/2010CN101724016A Peptide compound and preparation method and application thereof
06/09/2010CN101723813A Ethoxy diphenyl ethane derivative and preparation method and application thereof
06/09/2010CN101555215B Preparation technology of doxycycline hydrochloride for injection
06/09/2010CN101402706B Method for preparing tsiklomitsin molecular engram polymer used for water environment
06/08/2010US7732640 Process for urea production from ammonia and carbon dioxide
06/08/2010US7732429 Reducing tetracycline resistance in living cells
06/08/2010CA2144475C Polyamide-oligonucleotide derivatives, their preparation and use
06/03/2010WO2010060941A2 Contrast agents
06/03/2010WO2010036773A8 Deuterated 1-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives
06/03/2010WO2009074020A9 Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof
06/03/2010US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137296 N-phenyl anthranilic acid derivatives and uses thereof
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/02/2010EP2192111A2 Methods for synthesizing substituted tetracycline compounds
06/02/2010EP2190811A1 Renin inhibitors
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN101717393A Derivate of cyclohexyl 2, 5-2 substituted phenyl ether and application thereof
06/02/2010CN101717347A Method for preparing L-theanine by chemical method
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism
06/01/2010CA2490120C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
05/2010
05/27/2010WO2010060041A2 Phenylalanine amide inhibitors of atp-sensitive potassium channels
05/27/2010WO2010059967A2 Amide inhibitors of renin
05/27/2010WO2010058577A1 Method for producing unsaturated aminocarboxylic acid derivative
05/27/2010WO2010058353A1 Novel bis-amides as antimalarial agents
05/27/2010WO2009129387A3 Cationic lipids and uses thereof
05/27/2010US20100130757 Compositions and methods for detecting nerve agents
05/27/2010US20100130749 Methods
05/27/2010US20100130451 Synthesis of tetracyclines and analogues thereof
05/27/2010CA2742903A1 Novel bis-amides as antimalarial agents
05/26/2010EP2189444A1 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion
05/26/2010EP2189442A1 Process and intermediates for the preparation of aliskiren
05/26/2010EP2189434A1 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion
05/26/2010EP2189433A1 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion
05/26/2010EP2188256A1 Renin inhibitors
05/26/2010EP2188254A1 Novel bradykinin b1-antagonists
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010CN1849117B Entry inhibitors of the HIV virus
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 162